Susan Duggan
Chief Operating Officer at TRANSCODE THERAPEUTICS, INC.
Susan Duggan active positions
| Companies | Position | Start | End |
|---|---|---|---|
| TRANSCODE THERAPEUTICS, INC. | Chief Operating Officer | - | - |
Career history of Susan Duggan
Former positions of Susan Duggan
| Companies | Position | Start | End |
|---|---|---|---|
| MEDTRONIC PLC | Corporate Officer/Principal | - | - |
Samus Therapeutics, Inc.
 Samus Therapeutics, Inc. BiotechnologyHealth Technology Samus Therapeutics, Inc. operates as an biopharmaceutical company. It develops novel therapeutics targeting the epichaperome to enhance degradation of aberrant proteins which drive the pathology of diseases such as neurodegenerative and cancer. The company is headquartered in Topsfield, MA. | Corporate Officer/Principal | 28/02/2018 | - |
Training of Susan Duggan
| Colby-Sawyer College | Undergraduate Degree |
| Northern Essex Community College | Undergraduate Degree |
| Rivier University | Masters Business Admin |
Statistics
International
| United States | 6 |
| Ireland | 2 |
Operational
| Undergraduate Degree | 2 |
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| TRANSCODE THERAPEUTICS, INC. | Health Technology |
| MEDTRONIC PLC | Health Technology |
| Private companies | 1 |
|---|---|
Samus Therapeutics, Inc.
Samus Therapeutics, Inc. BiotechnologyHealth Technology Samus Therapeutics, Inc. operates as an biopharmaceutical company. It develops novel therapeutics targeting the epichaperome to enhance degradation of aberrant proteins which drive the pathology of diseases such as neurodegenerative and cancer. The company is headquartered in Topsfield, MA. | Health Technology |
- Stock Market
- Insiders
- Susan Duggan
- Experience
